Skip to main content
Top
Published in: Pediatric Nephrology 4/2020

01-04-2020 | Original Article

Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts

Authors: Lada Beara-Lasic, Andrea Cogal, Kristin Mara, Felicity Enders, Ramila A. Mehta, Zejfa Haskic, Susan L. Furth, Howard Trachtman, Steven J. Scheinman, Dawn S. Milliner, David S. Goldfarb, Peter C. Harris, John C. Lieske, On behalf of the investigators of the Rare Kidney Stone Consortium

Published in: Pediatric Nephrology | Issue 4/2020

Login to get access

Abstract

Background

Dent disease type 1 (DD1) is a rare X-linked disorder caused mainly by CLCN5 mutations. Patients may present with nephrotic-range proteinuria leading to erroneous diagnosis of focal segmental glomerulosclerosis (FSGS) and unnecessary immunosuppressive treatments.

Methods

The following cohorts were screened for CLCN5 mutations: Chronic Kidney Disease in Children (CKiD; n = 112); Multicenter FSGS-Clinical Trial (FSGS-CT) (n = 96), and Novel Therapies for Resistant FSGS Trial (FONT) (n = 30). Urinary α1-microglobulin (α1M), albumin (A), total protein (TP), and creatinine (Cr) were assessed from CKiD subjects (n = 104); DD1 patients (n = 14); and DD1 carriers (DC; n = 8). TP/Cr, α1M/Cr, α1M/TP, and A/TP from the CKiD cohort were compared with DD1 and DC.

Results

No CLCN5 mutations were detected. TP/Cr was lower in DC and CKiD with tubulointerstitial disease than in DD1 and CKiD with glomerular disease (p < 0.002). α1M/Cr was higher in DD1 than in CKiD and DC (p < 0.001). A/TP was lower in DD1, DC, and CKiD with tubulointerstitial disease and higher in CKiD with glomerular disease (p < 0.001). Thresholds for A/TP of ≤ 0.21 and α1M/Cr of ≥ 120 mg/g (> 13.6 mg/mmol) creatinine were good screens for Dent disease.

Conclusions

CLCN5 mutations were not seen in screened CKiD/FSGS cohorts. In our study, a cutoff of TP/Cr > 600 mg/g (> 68 mg/mmol) and A/TP of < 0.3 had a high sensitivity and specificity to distinguish DD1 from both CKiD glomerular and tubulointerstitial cohorts. α1M/Cr ≥ 120 mg/g (> 13.6 mg/mmol) had the highest sensitivity and specificity when differentiating DD1 and studied CKiD populations.
Literature
1.
go back to reference Dent CE, Friedman M (1964) Hypercalciuric rickets associated with renal tubular damage. Arch Dis Child 39:240–249CrossRef Dent CE, Friedman M (1964) Hypercalciuric rickets associated with renal tubular damage. Arch Dis Child 39:240–249CrossRef
2.
go back to reference Scheinman SJ (1998) X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int 53:3–17CrossRef Scheinman SJ (1998) X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int 53:3–17CrossRef
3.
go back to reference Lieske JC, Milliner DS, Beara-Lasic L, Harris P, Cogal A, Abrash E (2012, updated 2017) Dent disease. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (eds) GeneReviews®[Internet]. University of Washington: Seattle Lieske JC, Milliner DS, Beara-Lasic L, Harris P, Cogal A, Abrash E (2012, updated 2017) Dent disease. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (eds) GeneReviews®[Internet]. University of Washington: Seattle
4.
go back to reference Ludwig M, Utsch B, Monnens LA (2006) Recent advances in understanding the clinical and genetic heterogeneity of Dent’s disease. Nephrol Dial Transplant 21:2708–2717CrossRef Ludwig M, Utsch B, Monnens LA (2006) Recent advances in understanding the clinical and genetic heterogeneity of Dent’s disease. Nephrol Dial Transplant 21:2708–2717CrossRef
5.
go back to reference Frymoyer PA, Scheinman SJ, Dunham PB, Jones DB, Hueber P, Schroeder ET (1991) X-linked recessive nephrolithiasis with renal failure. N Engl J Med 325:681–686CrossRef Frymoyer PA, Scheinman SJ, Dunham PB, Jones DB, Hueber P, Schroeder ET (1991) X-linked recessive nephrolithiasis with renal failure. N Engl J Med 325:681–686CrossRef
6.
7.
go back to reference van Berkel Y, Ludwig M, van Wijk JAE, Bokenkamp A (2017) Proteinuria in Dent disease: a review of the literature. Pediatr Nephrol 32:1851–1859CrossRef van Berkel Y, Ludwig M, van Wijk JAE, Bokenkamp A (2017) Proteinuria in Dent disease: a review of the literature. Pediatr Nephrol 32:1851–1859CrossRef
8.
go back to reference Gambaro G, Vezzoli G, Casari G, Rampoldi L, D’Angelo A, Borghi L (2004) Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis 44:963–986CrossRef Gambaro G, Vezzoli G, Casari G, Rampoldi L, D’Angelo A, Borghi L (2004) Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis 44:963–986CrossRef
9.
go back to reference Copelovitch L, Nash MA, Kaplan BS (2007) Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol 2:914–918CrossRef Copelovitch L, Nash MA, Kaplan BS (2007) Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol 2:914–918CrossRef
10.
go back to reference Frishberg Y, Dinour D, Belostotsky R, Becker-Cohen R, Rinat C, Feinstein S, Navon-Elkan P, Ben-Shalom E (2009) Dent’s disease manifesting as focal glomerulosclerosis: is it the tip of the iceberg? Pediatr Nephrol 24:2369–2373CrossRef Frishberg Y, Dinour D, Belostotsky R, Becker-Cohen R, Rinat C, Feinstein S, Navon-Elkan P, Ben-Shalom E (2009) Dent’s disease manifesting as focal glomerulosclerosis: is it the tip of the iceberg? Pediatr Nephrol 24:2369–2373CrossRef
11.
go back to reference Fervenza FC (2013) A patient with nephrotic-range proteinuria and focal global glomerulosclerosis. Clin J Am Soc Nephrol 8:1979–1987CrossRef Fervenza FC (2013) A patient with nephrotic-range proteinuria and focal global glomerulosclerosis. Clin J Am Soc Nephrol 8:1979–1987CrossRef
12.
go back to reference Wrong OM, Norden AG, Feest TG (1994) Dent’s disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87:473–493 Wrong OM, Norden AG, Feest TG (1994) Dent’s disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87:473–493
13.
go back to reference Wang X, Anglani F, Beara-Lasic L, Mehta AJ, Vaughan LE, Herrera Hernandez L, Cogal A, Scheinman SJ, Ariceta G, Isom R, Copelovitch L, Enders FT, Del Prete D, Vezzoli G, Paglialonga F, Harris PC, Lieske JC, Investigators of the Rare Kidney Stone Consortium (2016) Glomerular pathology in Dent disease and its association with kidney function. Clin J Am Soc Nephrol 11:2168–2176CrossRef Wang X, Anglani F, Beara-Lasic L, Mehta AJ, Vaughan LE, Herrera Hernandez L, Cogal A, Scheinman SJ, Ariceta G, Isom R, Copelovitch L, Enders FT, Del Prete D, Vezzoli G, Paglialonga F, Harris PC, Lieske JC, Investigators of the Rare Kidney Stone Consortium (2016) Glomerular pathology in Dent disease and its association with kidney function. Clin J Am Soc Nephrol 11:2168–2176CrossRef
14.
go back to reference Wong CJ, Moxey-Mims M, Jerry-Fluker J, Warady BA, Furth SL (2012) CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis 60:1002–1011CrossRef Wong CJ, Moxey-Mims M, Jerry-Fluker J, Warady BA, Furth SL (2012) CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis 60:1002–1011CrossRef
15.
go back to reference Joy MS, Gipson DS, Dike M, Powell L, Thompson A, Vento S, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H (2009) Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group. Clin J Am Soc Nephrol 4:39–47CrossRef Joy MS, Gipson DS, Dike M, Powell L, Thompson A, Vento S, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H (2009) Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group. Clin J Am Soc Nephrol 4:39–47CrossRef
16.
go back to reference Ferris M, Norwood V, Radeva M, Gassman JJ, Al-Uzri A, Askenazi D, Matoo T, Pinsk M, Sharma A, Smoyer W, Stults J, Vyas S, Weiss R, Gipson D, Kaskel F, Friedman A, Moxey-Mims M, Trachtman H (2013) Patient recruitment into a multicenter randomized clinical trial for kidney disease: report of the focal segmental glomerulosclerosis clinical trial (FSGS CT). Clin Transl Sci 6:13–20CrossRef Ferris M, Norwood V, Radeva M, Gassman JJ, Al-Uzri A, Askenazi D, Matoo T, Pinsk M, Sharma A, Smoyer W, Stults J, Vyas S, Weiss R, Gipson D, Kaskel F, Friedman A, Moxey-Mims M, Trachtman H (2013) Patient recruitment into a multicenter randomized clinical trial for kidney disease: report of the focal segmental glomerulosclerosis clinical trial (FSGS CT). Clin Transl Sci 6:13–20CrossRef
17.
go back to reference Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRef Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRef
18.
go back to reference Bernard AM, Moreau D, Lauwerys R (1982) Comparison of retinol-binding protein and beta 2-microglobulin determination in urine for the early detection of tubular proteinuria. Clin Chim Acta 126:1–7CrossRef Bernard AM, Moreau D, Lauwerys R (1982) Comparison of retinol-binding protein and beta 2-microglobulin determination in urine for the early detection of tubular proteinuria. Clin Chim Acta 126:1–7CrossRef
19.
go back to reference Blumsohn A, Morris BW, Griffiths H, Ramsey CF (1991) Stability of beta 2-microglobulin and retinol binding protein at different values of pH and temperature in normal and pathological urine. Clin Chim Acta 195:133–137CrossRef Blumsohn A, Morris BW, Griffiths H, Ramsey CF (1991) Stability of beta 2-microglobulin and retinol binding protein at different values of pH and temperature in normal and pathological urine. Clin Chim Acta 195:133–137CrossRef
20.
go back to reference Guder WG, Hofmann W (2008) Clinical role of urinary low molecular weight proteins: their diagnostic and prognostic implications. Scand J Clin Lab Investig Suppl 241:95–98CrossRef Guder WG, Hofmann W (2008) Clinical role of urinary low molecular weight proteins: their diagnostic and prognostic implications. Scand J Clin Lab Investig Suppl 241:95–98CrossRef
21.
go back to reference Norden AG, Scheinman SJ, Deschodt-Lanckman MM, Lapsley M, Nortier JL, Thakker RV, Unwin RJ, Wrong O (2000) Tubular proteinuria defined by a study of Dent’s (CLCN5 mutation) and other tubular diseases. Kidney Int 57:240–249CrossRef Norden AG, Scheinman SJ, Deschodt-Lanckman MM, Lapsley M, Nortier JL, Thakker RV, Unwin RJ, Wrong O (2000) Tubular proteinuria defined by a study of Dent’s (CLCN5 mutation) and other tubular diseases. Kidney Int 57:240–249CrossRef
22.
go back to reference Bokenkamp A, Bockenhauer D, Cheong HI, Hoppe B, Tasic V, Unwin R, Ludwig M (2009) Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr 155:94–99CrossRef Bokenkamp A, Bockenhauer D, Cheong HI, Hoppe B, Tasic V, Unwin R, Ludwig M (2009) Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr 155:94–99CrossRef
23.
go back to reference Lloyd SE, Pearce SHS, Guenther W, Kawaguchi H, Igarashi T, Jentsch TJ, Thakker RV (1997) Idiopathic low molecular weight proteinuria associated with hypercalciuric nephroclacinosis in Japanese children is due to mutations of teh renal chloride channel (CLCN5). J Clin Invest 99:967–974CrossRef Lloyd SE, Pearce SHS, Guenther W, Kawaguchi H, Igarashi T, Jentsch TJ, Thakker RV (1997) Idiopathic low molecular weight proteinuria associated with hypercalciuric nephroclacinosis in Japanese children is due to mutations of teh renal chloride channel (CLCN5). J Clin Invest 99:967–974CrossRef
24.
go back to reference Tada M, Jimi S, Hisano S, Sasatomi Y, Oshima K, Matsuoka H, Takebayashi S (2001) Histopathological evidence of poor prognosis in patients with vesicoureteral reflux. Pediatr Nephrol 16:482–487CrossRef Tada M, Jimi S, Hisano S, Sasatomi Y, Oshima K, Matsuoka H, Takebayashi S (2001) Histopathological evidence of poor prognosis in patients with vesicoureteral reflux. Pediatr Nephrol 16:482–487CrossRef
25.
go back to reference van Berkel Y, Ludwig M, van Wijk JA, Bokenkamp A (2016) Proteinuria in Dent disease: a review of the literature. Pediatr Nephrol 32:1851–1859CrossRef van Berkel Y, Ludwig M, van Wijk JA, Bokenkamp A (2016) Proteinuria in Dent disease: a review of the literature. Pediatr Nephrol 32:1851–1859CrossRef
26.
go back to reference Ceol M, Tiralongo E, Baelde HJ, Vianello D, Betto G, Marangelli A, Bonfante L, Valente M, Della Barbera M, D’Angelo A, Anglani F, Del Prete D (2012) Involvement of the tubular ClC-type exchanger ClC-5 in glomeruli of human proteinuric nephropathies. PLoS One 7:e45605CrossRef Ceol M, Tiralongo E, Baelde HJ, Vianello D, Betto G, Marangelli A, Bonfante L, Valente M, Della Barbera M, D’Angelo A, Anglani F, Del Prete D (2012) Involvement of the tubular ClC-type exchanger ClC-5 in glomeruli of human proteinuric nephropathies. PLoS One 7:e45605CrossRef
27.
go back to reference Erb BC, Velazquez H, Gisser M, Shugrue CA, Reilly RF (1997) cDNA cloning and localization of OCRL-1 in rabbit kidney. Am J Phys 273:F790–F795CrossRef Erb BC, Velazquez H, Gisser M, Shugrue CA, Reilly RF (1997) cDNA cloning and localization of OCRL-1 in rabbit kidney. Am J Phys 273:F790–F795CrossRef
28.
go back to reference Prabakaran T, Christensen EI, Nielsen R, Verroust PJ (2012) Cubilin is expressed in rat and human glomerular podocytes. Nephrol Dial Transplant 27:3156–3159CrossRef Prabakaran T, Christensen EI, Nielsen R, Verroust PJ (2012) Cubilin is expressed in rat and human glomerular podocytes. Nephrol Dial Transplant 27:3156–3159CrossRef
29.
go back to reference Prabakaran T, Nielsen R, Larsen JV, Sorensen SS, Feldt-Rasmussen U, Saleem MA, Petersen CM, Verroust PJ, Christensen EI (2011) Receptor-mediated endocytosis of alpha-galactosidase A in human podocytes in Fabry disease. PLoS One 6:e25065CrossRef Prabakaran T, Nielsen R, Larsen JV, Sorensen SS, Feldt-Rasmussen U, Saleem MA, Petersen CM, Verroust PJ, Christensen EI (2011) Receptor-mediated endocytosis of alpha-galactosidase A in human podocytes in Fabry disease. PLoS One 6:e25065CrossRef
Metadata
Title
Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts
Authors
Lada Beara-Lasic
Andrea Cogal
Kristin Mara
Felicity Enders
Ramila A. Mehta
Zejfa Haskic
Susan L. Furth
Howard Trachtman
Steven J. Scheinman
Dawn S. Milliner
David S. Goldfarb
Peter C. Harris
John C. Lieske
On behalf of the investigators of the Rare Kidney Stone Consortium
Publication date
01-04-2020
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 4/2020
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-019-04210-0

Other articles of this Issue 4/2020

Pediatric Nephrology 4/2020 Go to the issue